Status:
COMPLETED
Prediction of Response to IUCD Associated Menorrhagia Using Doppler
Lead Sponsor:
Ain Shams University
Conditions:
Women's Health: Amenorrhea/Dysmenorrhea
Eligibility:
FEMALE
20-35 years
Phase:
NA
Brief Summary
Studying the efficacy of uterine artery doppler in predicting response to mefenamic acid in women having IUCD associated menorrhagia
Eligibility Criteria
Inclusion
- women in chile bearing period (age 20-35 yrs ) with history of regular menstrual cycle presenting with recent onset of more then three months menorrhagia after IUCD "copper T 380 A" insertion
Exclusion
- history of bleeding tendency
- history of abnormal uterine bleeding due to other causes
- history of active liver disease
- history of antiplatelet or anticoagulant intake in the last month
- history of thyroid disease
- history of endometritis
- history of allergy to NSAIDs
- Adenomyosis
- women having contraindications to use NSAIDs e.g. peptic ulcer
- Insulin dependant diabetes mellitus
Key Trial Info
Start Date :
May 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2018
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT03794895
Start Date
May 1 2017
End Date
May 1 2018
Last Update
January 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AinshamsU
Cairo, Abbaseya, Egypt, 11511